Clinical trial
Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
NCT00087282 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00087282 |
|---|---|
| Title | Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer |
| Official title | A Non-Randomized Phase II Study of Sequential Irinotecan (CPT-11) And Flavopiridol In Patients With Advanced Hepatoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Liver Cancer |
| Intervention type | Drug |
| Interventions | alvocidib, irinotecan hydrochloride |
| Start date | Jun 1, 2004 |
| Completion | Jul 1, 2006 |
| First posted | Jul 12, 2004 |
| Last update posted | Jun 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: